UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 15, 2010 4:30 P.M.
Form: S-1
CIK: 0001473579
Company Name: AVANYX Therapeutics, Inc.
File Number: 333-164785